Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling.

J Cell Mol Med · 2008 · PMC4506175 · PMID 18194453

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Significant or highly significant reduction in CD25 (Fig. 3 , panel A) and CD69 (Fig. 3 , panel B) expression was observed at 4 μM nilotinib.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.